Declining Guillain-Barre Syndrome after Campylobacteriosis Control, New Zealand, 1988-2010

被引:40
作者
Baker, Michael G. [1 ]
Kvalsvig, Amanda
Zhang, Jane
Lake, Rob [2 ]
Sears, Ann
Wilson, Nick
机构
[1] Univ Otago, Dept Publ Hlth, Wellington 6242, New Zealand
[2] Inst Environm Sci & Res, Christchurch, New Zealand
关键词
INFLUENZA; INFECTIONS; DISEASE; VIRUS; RATES;
D O I
10.3201/eid1802.111126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection with Campylobacter spp. commonly precedes Guillain-Barre syndrome (GBS). We therefore hypothesized that GBS incidence may have followed a marked rise and then decline in campylobacteriosis rates in New Zealand. We reviewed records for 1988-2010: hospitalization records for GBS case-patients and campylobacteriosis case-patients plus notifications of campylobacteriosis. We identified 2,056 first hospitalizations for GBS, an average rate of 2.32 hospitalizations/100,000 population/year. Annual rates of hospitalization for GBS were significantly correlated with rates of notifications of campylobacteriosis. For patients hospitalized for campylobacteriosis, risk of being hospitalized for GBS during the next month was greatly increased. Three years after successful interventions to lower Campylobacter spp. contamination of fresh poultry meat, notifications of campylobacteriosis had declined by 52% and hospitalizations for GBS by 13%. Therefore, regulatory measures to prevent foodborne campylobacteriosis probably have an additional health and economic benefit of preventing GBS.
引用
收藏
页码:226 / 233
页数:8
相关论文
共 33 条
  • [1] Guillain-Barre syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature
    Abbi, Kamal K. S.
    Rizvi, Syed M.
    Sivik, Jeffrey
    Thyagarajan, Subramanian
    Loughran, Thomas
    Drabick, Joseph J.
    [J]. LEUKEMIA RESEARCH, 2010, 34 (07) : E154 - E156
  • [2] Guillain-Barre syndrome - Incidence and mortality rates in US hospitals
    Alshekhlee, Amer
    Hussain, Zulfiqar
    Sultan, Badr
    Katirji, Bashar
    [J]. NEUROLOGY, 2008, 70 (18) : 1608 - 1613
  • [3] [Anonymous], 2008, Modern epidemiology
  • [4] Is the major increase in notified campylobacteriosis in New Zealand real?
    Baker, M. G.
    Sneyd, E.
    Wilson, N. A.
    [J]. EPIDEMIOLOGY AND INFECTION, 2007, 135 (01) : 163 - 170
  • [5] Baker Michael, 2006, N Z Med J, V119, pU2264
  • [6] Baker MG, 2011, NEW ZEAL MED J, V124, P135
  • [7] A surveillance sector review applied to infectious diseases at a country level
    Baker, Michael G.
    Easther, Sally
    Wilson, Nick
    [J]. BMC PUBLIC HEALTH, 2010, 10
  • [8] Long-term impact on work and private life after Guillain-Barre syndrome
    Bernsen, RAJAM
    de Jager, AEJ
    Schmitz, PIM
    van der Meché, FGA
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 201 (1-2) : 13 - 17
  • [9] Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
    Black, Steven
    Eskola, Juhani
    Siegrist, Claire-Anne
    Halsey, Neal
    MacDonald, Noni
    Law, Barbara
    Miller, Elizabeth
    Andrews, Nick
    Stowe, Julia
    Salmon, Daniel
    Vannice, Kirsten
    Izurieta, Hector S.
    Akhtar, Aysha
    Gold, Mike
    Oselka, Gabriel
    Zuber, Patrick
    Pfeifer, Dina
    Vellozzi, Claudia
    [J]. LANCET, 2009, 374 (9707) : 2115 - 2122
  • [10] Cheng Q, 2000, EUR J NEUROL, V7, P11, DOI 10.1046/j.1468-1331.2000.00006.x